Skip to main content
Premium Trial:

Request an Annual Quote

UT-Austin Scientist Snags $2.5M NIH Pioneer Award

NEW YORK (GenomeWeb News) – A University of Texas at Austin investigator has won a $2.5 million award from the National Institutes of Health to fund his lab's efforts to develop a systems biology-based method to map relationships between genes and proteins, the university said yesterday.

UT-Austin Professor Edward Marcotte will use the five-year NIH Director's Pioneer Award to develop a highly parallel method for identifying and quantifying individual proteins in samples that could be useful in diagnosing cancer and in characterizing proteins and discovering new biomarkers.

"It will have broad applications across biology and medicine," Marcotte, who is co-director of the Center for Systems and Synthetic Biology in the College of Natural Sciences, said in a statement.

He noted that next-generation sequencing has "transformed biology," but he also explained that identifying specific proteins still poses a challenge.

"Unfortunately, no method of similar scale and throughput yet exists to identify and quantify specific proteins in complex mixtures, representing a critical bottleneck in many biochemical, molecular diagnostic, and biomarker discovery assays," Marcotte said.

The research in Marcotte's lab focuses on large-scale organization of proteins, specifically seeking to understand how the proteins in a genome are associated into functional pathways, systems, and networks. These efforts involve using computational approaches and experimental studies involving high-throughput functional genomics and proteomics to study thousands of genes and proteins in parallel, according to the Marcotte Lab website.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.